Assembly Biosciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Assembly Biosciences, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 89% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-199.0×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 89% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-72.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 78% of Healthcare companies in United States.
Cash Cushion Ratio
+59%Cash, after subtracting all debt, equals 59% of its market value (net cash).
Higher than 80% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Assembly Biosciences, Inc. owes $0.08 for every $1 it owns. Assembly Biosciences, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
19.5Investors pay $19.5 for every $1 of Assembly Biosciences, Inc.'s yearly profit, lower than 64% of Healthcare companies in United States.
P/B ratio
1.35The share price is 1.35 times Assembly Biosciences, Inc.'s book value per share, lower than 72% of Healthcare companies in United States.
Market cap
$413 MThe total market value of all of Assembly Biosciences, Inc.'s shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$306 MWhat Assembly Biosciences, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$15.01Net worth divided by the number of shares. The share price of $20.28 is 1.4 times this, which is the P/B above.
Return on equity (ROE)
-0.0%Assembly Biosciences, Inc. lost 0.0% of its shareholders' money over the last year, higher than 76% of Healthcare companies in United States.
Owes vs Owns
0.08×Assembly Biosciences, Inc. owes $0.08 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Dividend yield
NoneAssembly Biosciences, Inc. does not currently pay a dividend.
Revenue growth
+154%Revenue rose 154% in the year to Dec 2025.
Profit growth
LossAssembly Biosciences, Inc. made a loss in each of the last two years.
Profit margin
-8.5%Assembly Biosciences, Inc. lost $8 for every $100 of revenue.
Cash vs debt
Net cashAssembly Biosciences, Inc. held $245 M more cash than debt (net cash) at Dec 2025.
Questions
What is Assembly Biosciences, Inc.'s P/E ratio?
Investors pay $19.5 for every $1 of Assembly Biosciences, Inc.'s yearly profit, lower than 64% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Assembly Biosciences, Inc.: $413 M ÷ $306 M (30 Jun 2026) = 1.4.
What is Assembly Biosciences, Inc.'s return on equity?
Assembly Biosciences, Inc. lost 0.0% of its shareholders' money over the last year, higher than 76% of Healthcare companies in United States.
How much does Assembly Biosciences, Inc. owe compared with what it owns?
Assembly Biosciences, Inc. owes $0.08 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Does Assembly Biosciences, Inc. pay a dividend?
No. Assembly Biosciences, Inc. does not currently pay a dividend.
Is Assembly Biosciences, Inc.'s revenue growing?
Revenue rose 154% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.